In line with this and accounting for a role in liver fibrosis, an increased expression of CCN1 has been shown in the liver of NASH patients [395], in hepatocytes of the human cirrhotic liver, and as a reaction to liver injury [396]. Here, CCN1 is linked to metabolic dysfunction-associated steatohepatitis.